1. Vogelzang, NJ, Nelimark, RA, Nath, KA. Tumor lysis syndrome after induction chemotherapy of small-cell bronchogenic carcinoma. JAMA. 1983;249:513-514.
Google Scholar | Crossref | Medline | ISI2. Cairo, MS, Bishop, M. Tumour lysis syndrome: new therapeutic strategies and classification. Br J Haematol. 2004;127:3-11. doi:10.1111/j.1365-2141.2004.05094.x.
Google Scholar | Crossref | Medline | ISI3. Annemans, L, Moeremans, K, Lamotte, M, et al. Incidence, medical resource utilisation and costs of hyperuricemia and tumour lysis syndrome in patients with acute leukaemia and non-Hodgkin’s lymphoma in four European countries. Leuk Lymphoma. 2003;44:77-83. doi:10.1080/1042819021000054661.
Google Scholar | Crossref | Medline | ISI4. Cairo, MS, Coiffier, B, Reiter, A, Younes, A; TLS Expert Panel. Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus. Br J Haematol. 2010;149:578-586. doi:10.1111/j.1365-2141.2010.08143.x.
Google Scholar | Crossref | Medline | ISI5. Kawaguchi Ushio, A, Hattori, M, Kohno, N, Kaise, H, Iwata, H. Gemcitabine-induced tumour lysis syndrome caused by recurrent breast cancer in a patient without haemodialysis. Gan To Kagaku Ryoho. 2013;40:1529-1532.
Google Scholar | Medline6. https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/020726s014lbl.pdf. Accessed January 3, 2020.
Google Scholar7. Zigrossi, P, Brustia, M, Bobbio, F, Campanini, M. Flare and tumor lysis syndrome with atypical features after letrozole therapy in advanced breast cancer. A case report. Ann Ital Med Int. 2001;16:112-117.
Google Scholar | Medline8. Mirrakhimov, AE, Ali, AM, Khan, M, Barbaryan, A. Tumor lysis syndrome in solid tumors: an up to date review of the literature. Rare Tumors. 2014;6:5389. doi:10.4081/rt.2014.5389.
Google Scholar | SAGE Journals9. Cech, P, Block, JB, Cone, LA, Stone, R. Tumor lysis syndrome after tamoxifen flare. N Engl J Med. 1986;315:263-264. doi:10.1056/NEJM198607243150417.
Google Scholar | Crossref | Medline | ISI10. Sklarin, NT, Markham, M. Spontaneous recurrent tumor lysis syndrome in breast cancer. Am J Clin Oncol. 1995;18:71-73. doi:10.1097/00000421-199502000-00015.
Google Scholar | Crossref | Medline | ISI11. Idrees, M, Fatima, S, Bravin, E. Spontaneous tumor lysis syndrome: a rare presentation in breast cancer. J Med Case. 2019;10:24-26. https://journalmc.org/index.php/JMC/article/view/3237/2532
Google Scholar12. Parsi, M, Rai, M, Clay, C. You can’t always blame the chemo: a rare case of spontaneous tumor lysis syndrome in a patient with invasive ductal cell carcinoma of the breast. Cureus. 2019;11:e6186. doi:10.7759/cureus.6186.
Google Scholar | Crossref13. Rostom, AY, El-Hussainy, G, Kandil, A, Allam, A. Tumor lysis syndrome following hemi-body irradiation for metastatic breast cancer. Ann Oncol. 2000;11:1349-1351. doi:10.1023/a:1008347226743.
Google Scholar | Crossref | Medline | ISI14. Bromberg, DJ, Valenzuela, M, Nanjappa, S, Pabbathi, S. Hyperuricemia in 2 patients receiving palbociclib for breast cancer. Cancer Control. 2016;23:59-60. doi:10.1177/107327481602300110.
Google Scholar | SAGE Journals | ISI15. Mott, FE, Esana, A, Chakmakjian, C, Herrington, JD. Tumor lysis syndrome in solid tumors. Support Cancer Ther. 2005;2:188-191. doi:10.3816/SCT.2005.n.012.
Google Scholar | Crossref | Medline16. Aslam, HM, Zhi, C, Wallach, SL. Tumor lysis syndrome: a rare complication of chemotherapy for metastatic breast cancer. Cureus. 2019;11:e4024. doi:10.7759/cureus.4024.
Google Scholar17. Baudon, C, Duhoux, FP, Sinapi, I, Canon, JL. Tumor lysis syndrome following trastuzumab and pertuzumab for metastatic breast cancer: a case report. J Med Case Rep. 2016;10:178. doi:10.1186/s13256-016-0969-5.
Google Scholar | Crossref | Medline18. Taira, F, Horimoto, Y, Saito, M. Tumor lysis syndrome following trastuzumab for breast cancer: a case report and review of the literature. Breast Cancer. 2015;22:664-668. doi:10.1007/s12282-013-0448-4.
Google Scholar | Crossref | Medline19. Stark, ME, Dyer, MC, Coonley, CJ. Fatal acute tumor lysis syndrome with metastatic breast carcinoma. Cancer. 1987;60:762-764. doi:10.1002/1097-0142(19870815)60.
Google Scholar | Crossref | Medline | ISI20. Vaidya, GN, Acevedo, R. Tumor lysis syndrome in metastatic breast cancer after a single dose of paclitaxel. Am J Emerg Med. 2015;33:308.e1-2. doi:10.1016/j.ajem.2014.07.039.
Google Scholar | Crossref21. Ustündağ, Y, Boyacioğlu, S, Haznedaroğlu, IC, Baltali, E. Acute tumor lysis syndrome associated with paclitaxel. Ann Pharmacother. 1997;31:1548-1549. doi:10.1177/106002809703101221.
Google Scholar | SAGE Journals | ISI22. Kurt, M, Eren, OO, Engin, H, Güler, N. Tumor lysis syndrome following a single dose of capecitabine. Ann Pharmacother. 2004;38:902. doi:10.1345/aph.1D164.
Google Scholar | SAGE Journals | ISI23. Drakos, P, Bar-Ziv, J, Catane, R. Tumor lysis syndrome in nonhematologic malignancies. Report of a case and review of the literature. Am J Clin Oncol. 1994;17:502-505. doi:10.1097/00000421-199412000-00010.
Google Scholar | Crossref | Medline | ISI24. Abodief, WT, Dey, P, Al-Hattab, O. Cell cannibalism in ductal carcinoma of breast. Cytopathology. 2006;17:304-305. doi:10.1111/j.1365-2303.2006.00326.x.
Google Scholar | Crossref | Medline25. Siddiqui, S, Singh, A, Faizi, N, Khalid, A. Cell cannibalism in oral cancer: a sign of aggressiveness, de-evolution, and retroversion of multicellularity. J Cancer Res Ther. 2019;15:631-637. doi:10.4103/jcrt.JCRT_504_17.
Google Scholar | Crossref | Medline